NAP1L1: A Novel Human Colorectal Cancer Biomarker Derived From Animal Models of Apc Inactivation
IntroductionColorectal cancer (CRC) is the second leading cause of cancer death worldwide and most deaths result from metastases. We have analyzed animal models in which Apc, a gene that is frequently mutated during the early stages of colorectal carcinogenesis, was inactivated and human samples to...
Main Authors: | Cleberson J. S. Queiroz, Fei Song, Karen R. Reed, Nadeem Al-Khafaji, Alan R. Clarke, Dale Vimalachandran, Fabio Miyajima, D. Mark Pritchard, John R. Jenkins |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01565/full |
Similar Items
-
Napping Areas and Nap Pods in Academic Library
by: fauzan hidayatullah, et al.
Published: (2022-12-01) -
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
by: Yong Le, et al.
Published: (2019-09-01) -
APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression
by: Noha-Ehssan Mohamed, et al.
Published: (2019-07-01) -
NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth
by: Shu Liu, et al.
Published: (2021-11-01) -
The experience of a Power Nap Center in the largest city of Brazil
by: Rogerio Santos-Silva, et al.
Published: (2016-07-01)